These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20099200)

  • 1. Increased ubiquitination of multidrug resistance 1 by ginsenoside Rd.
    Pokharel YR; Kim ND; Han HK; Oh WK; Kang KW
    Nutr Cancer; 2010; 62(2):252-9. PubMed ID: 20099200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells.
    Han CY; Cho KB; Choi HS; Han HK; Kang KW
    Carcinogenesis; 2008 Sep; 29(9):1837-44. PubMed ID: 18390843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
    Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
    Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1.
    Oh WK; Cho KB; Hien TT; Kim TH; Kim HS; Dao TT; Han HK; Kwon SM; Ahn SG; Yoon JH; Kim TH; Kim YG; Kang KW
    Mol Pharmacol; 2010 Nov; 78(5):855-64. PubMed ID: 20713551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2.
    Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G
    Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversal of adriamycin resistance by digoxin in human breast cancer cell line MCF-7/adriamycin and its mechanism].
    Li BH; Yuan L; Shi RR; Wang JG
    Sheng Li Xue Bao; 2015 Dec; 67(6):611-7. PubMed ID: 26701637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
    Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC
    Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
    Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
    Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant transcriptional down-regulation of the human MDR1 gene by beta-naphthoflavone: a proposed hypothesis linking potent CYP gene induction to MDR1 inhibition.
    Nwankwo JO
    Med Hypotheses; 2007; 68(3):661-9. PubMed ID: 17011724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.
    Zhang X; Wu X; Li J; Sun Y; Gao P; Zhang C; Zhang H; Zhou G
    J Surg Oncol; 2011 Oct; 104(5):466-71. PubMed ID: 21538359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X; Chang Z; Song J; Gao G; Shen Z
    Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells.
    Yu ST; Chen TM; Tseng SY; Chen YH
    Biochem Biophys Res Commun; 2007 Jun; 358(1):79-84. PubMed ID: 17482571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A; Wang X; Xiang W; Liang H; Gao J; Yan Y
    J Pharm Pharmacol; 2010 Mar; 62(3):393-9. PubMed ID: 20487225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y.
    Tanaka H; Ohshima N; Ikenoya M; Komori K; Katoh F; Hidaka H
    Cancer Res; 2003 Oct; 63(20):6942-7. PubMed ID: 14583495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C; Goubin F; Ferrandis E; Cornil-Scharwtz I; Bailly JD; Bordier C; Bénard J; Sikic BI; Laurent G
    Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
    Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
    Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
    Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B; Safa AR
    Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.